Blood Screening Market By Technology, Product & End User - Global Industry Analysis And Forecast To 2023
Published On : April 2018 Pages : 100 Category: Biotechnology Report Code : HC04717
The Blood Screening Market was worth USD 1.35 billion in 2017 and is expected to reach approximately USD 3.10 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.68% during the forecast period. Blood Screening is the key part to prevent degenerative infection. By giving a far reaching preview of your present condition of wellbeing, blood screening can detect potential medical issues. Increasing numbers of blood donors and blood donations coupled with rising awareness about safety of donated blood are the key factors that are propelling the growth of Blood Screening Market.
Technology Outlook and Trend Analysis
According to the Type the market of Blood Screening is divided into NGS, Nucleic Acid Amplification (NAT), ELISA, (CLIA, Fluorescence assay), (rPCR), Western Blotting, Rapid Test. Due to its increasing affordability, accuracy, and other factors such as rise in number of blood donors. NAT is one of the major players in the market. It is further segmented into Transcription-Mediated Amplification (TMA) and Real-Time PCR. Also the ELISA test is further divided into Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassays (FIA), and Colorimetric Immunoassay (CI).
Product Outlook and Trend Analysis
Reagents & Kits, Instruments, and Software & Services are various categories into which the product segment is divided into. The Reagents & Kits segment is further categorised as ELISA Reagents & Kits, NAT Reagent & Kits, and Others. The Reagent & Kits segment is predicted to dominate throughout the forecast period owing to increasing demand.
End User Outlook and Trend Analysis
The End User segment is fragmented into Hospitals and Blood Bank. The Blood bank sector is expected to rule the market whilst holding the largest share due to increasing incidents of blood donations, increasing no. of donors and huge number of organ replacements and organ donations taking place across the world.
Regional Outlook and Trend Analysis
According to the region, the Blood Screening Market is segmented as North America, Asia-Pacific, Europe and South America and Middle East & Africa. The North-America Region is expected to rule the market in terms of volume as well as value which is followed by Europe. The Asia-Pacific Market is expected to grow at highest CAGR during the forecast period owing to increasing demand for blood screening in the countries like India, China and Japan. The key aspects that fuel the development of the worldwide blood screening market incorporate increment in pervasiveness of irresistible infections, ascend in number of blood gifts, increment in mindfulness about social insurance, and surge in appropriation of nucleic acid amplification test (NAT). Besides, ascend in social insurance activities by government, increment in medicinal services use, and mechanical progressions in blood screening advancements have energized the market development.
Competitive Insights
The leading players in the market are Bio-Rad Laboratories Inc., Abbott Laboratories, Becton, Dickinson and Company, Beckman Coulter Inc., Ortho Clinical Diagnostics Inc., Thermo Fisher Scientific Inc., bioMérieux, Siemens Healthineers, Roche Diagnostics, and Grifols. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Blood Screening Market is segmented as follows-
By Test Type:
- NGS
- Nucleic Acid Amplification (NAT)
- ELISA (CLIA, Fluorescence assay)
- Western Blotting
- Rapid Test
By Product Type:
- Reagents & Kits
- Instruments
- Software & Services
By End User:
- Hospitals
- Blood Banks
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Blood Screening Market, By Test Type, Estimates and Forecast, 2014-2023 ($Million)
o NGS, Nucleic Acid Amplification (NAT)
o ELISA (CLIA, Fluorescence assay)
o Western Blotting
o Rapid Test
· Blood Screening Market, By Product Type, Estimates and Forecast, 2014-2023 ($Million)
o Reagents & Kits
o Instruments
o Software & Services
· Blood Screening Market, By End User, Estimates and Forecast, 2014-2023 ($Million)
o Hospitals
o Blood Banks
· Blood Screening Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
o North America
§ North America Blood Screening Market, By Country
o U.S. Blood Screening Market
o Canada Blood Screening Market
o Mexico Blood Screening Market
o Europe
§ Europe Blood Screening Market, By Country
o Germany Blood Screening Market
o UK Blood Screening Market
o France Blood Screening Market
o Russia Blood Screening Market
o Italy Blood Screening Market
o Rest of Europe Blood Screening Market
o Asia-Pacific
§ Asia-Pacific Blood Screening Market, By Country
o China Blood Screening Market
o Japan Blood Screening Market
o South Korea Blood Screening Market
o India Blood Screening Market
o Southeast Asia Blood Screening Market
o Rest of Asia-Pacific Blood Screening Market
o South America
§ South America Blood Screening Market
o Brazil Blood Screening Market
o Argentina Blood Screening Market
o Columbia Blood Screening Market
o South Africa Blood Screening Market
o Rest of South America Blood Screening Market
o Middle East and Africa
§ Middle East and Africa Blood Screening Market
o Saudi Arabia Blood Screening Market
o UAE Blood Screening Market
o Egypt Blood Screening Market
o Nigeria Blood Screening Market
o South Africa Blood Screening Market
o Rest of MEA Blood Screening Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Numbers of Blood Donors and Blood Donations.
3.2.1.2. Increasing Demand for Blood Due to Various Medical Procedures.
3.2.1.3. Increasing Awareness about Infectious Diseases.
3.2.1.4. Affordability of Tests.
3.2.2. Restraints
3.2.2.1. Emerging Alternative Technologies.
3.2.2.2. Lack of Rules and Regulations in Developing Countries.
3.2.3. Opportunities
3.2.3.1. Multiplex Tests
3.2.3.2. Pathogen Reduction Technology.
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Blood Screening Market, By Test Type
5.1. Introduction
5.2. Global Blood Screening Sales, Revenue and Market Share By Test Type (2017-2027)
5.2.1. Global Blood Screening Sales and Sales Share By Test Type (2017-2027)
5.2.2. Global Blood Screening Revenue and Revenue Share By Test Type (2017-2027)
5.3. NGS
5.3.1. Global NGS Sales and Growth Rate (2017-2027)
5.4. Nucleic Acid Amplification (NAT)
5.4.1. Global Nucleic Acid Amplification (NAT) Sales and Growth Rate (2017-2027)
5.5. ELISA (CLIA, Fluorescence assay)
5.5.1. Global ELISA (CLIA, Fluorescence assay) Sales and Growth Rate (2017-2027)
5.6. Western Blotting
5.6.1. Global Western Blotting Sales and Growth Rate (2017-2027)
5.7. Rapid Test
5.7.1. Global Rapid Test Sales and Growth Rate (2017-2027)
6. Blood Screening Market, By Product
6.1. Introduction
6.2. Global Blood Screening Sales, Revenue and Market Share by Product (2017-2027)
6.2.1. Global Blood Screening Sales and Sales Share by Product (2017-2027)
6.2.2. Global Blood Screening Revenue and Revenue Share by Product (2017-2027)
6.3. Reagents & Kits
6.3.1. Global Reagents & Kits Sales and Growth Rate (2017-2027)
6.4. Instruments
6.4.1. Global Instruments Sales and Growth Rate (2017-2027)
6.5. Software & Services
6.5.1. Global Software & Services Sales and Growth Rate (2017-2027)
7. Blood Screening Market, By End User
7.1. Introduction
7.2. Global Blood Screening Sales, Revenue and Market Share By End User (2017-2027)
7.2.1. Global Blood Screening Sales and Sales Share By End User (2017-2027)
7.2.2. Global Blood Screening Revenue and Revenue Share By End User (2017-2027)
7.3. Hospitals
7.3.1. Global Hospitals Sales and Growth Rate (2017-2027)
7.4. Blood Banks
7.4.1. Global Blood Banks Sales and Growth Rate (2017-2027)
8. Blood Screening Market, By Region
8.1. Introduction
8.2. Global Blood Screening Sales, Revenue and Market Share by Regions
8.2.1. Global Blood Screening Sales by Regions (2017-2027)
8.2.2. Global Blood Screening Revenue by Regions (2017-2027)
8.3. North America Blood Screening by Countries
8.3.1. North America Blood Screening Sales and Growth Rate (2017-2027)
8.3.2. North America Blood Screening Revenue and Growth Rate (2017-2027)
8.3.3. North America Blood Screening Sales by Countries (2017-2027)
8.3.4. North America Blood Screening Revenue (Million USD) by Countries (2017-2027)
8.3.5. U.S.
8.3.5.1. United States Blood Screening Sales and Growth Rate (2017-2027)
8.3.5.2. United States Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.6. Canada
8.3.6.1. Canada Blood Screening Sales and Growth Rate (2017-2027)
8.3.6.2. Canada Blood Screening Sales (Millions USD) and Growth Rate (2017-2027)
8.3.7. Mexico
8.3.7.1. Mexico Blood Screening Sales and Growth Rate (2017-2027)
8.3.7.2. Mexico Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Blood Screening by Countries
8.4.1. Europe Blood Screening Sales and Growth Rate (2017-2027)
8.4.2. Europe Blood Screening Revenue and Growth Rate (2017-2027)
8.4.3. Europe Blood Screening Sales by Countries (2017-2027)
8.4.4. Europe Blood Screening Revenue (Million USD) by Countries (2017-2027)
8.4.5. Germany
8.4.5.1. Germany Blood Screening Sales and Growth Rate (2017-2027)
8.4.5.2. Germany Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. UK
8.4.6.1. UK Blood Screening Sales and Growth Rate (2017-2027)
8.4.6.2. UK Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. France
8.4.7.1. France Blood Screening Sales and Growth Rate (2017-2027)
8.4.7.2. France Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Russia
8.4.8.1. Russia Blood Screening Sales and Growth Rate (2017-2027)
8.4.8.2. Russia Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.9. Italy
8.4.9.1. Italy Blood Screening Sales and Growth Rate (2017-2027)
8.4.9.2. Italy Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.10. Rest of Europe
8.4.10.1. Rest of Europe Blood Screening Sales and Growth Rate (2017-2027)
8.4.10.2. Rest of Europe Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific
8.5.1. Asia-Pacific Blood Screening Sales and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Blood Screening Revenue and Growth Rate (2017-2027)
8.5.3. Asia-Pacific Blood Screening Sales by Countries (2017-2027)
8.5.4. Asia-Pacific Blood Screening Revenue (Million USD) by Countries (2017-2027)
8.5.5. China
8.5.5.1. China Blood Screening Sales and Growth Rate (2017-2027)
8.5.5.2. China Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. Japan
8.5.6.1. Japan Blood Screening Sales and Growth Rate (2017-2027)
8.5.6.2. Japan Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Korea
8.5.7.1. Korea Blood Screening Sales and Growth Rate (2017-2027)
8.5.7.2. Korea Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. India
8.5.8.1. India Blood Screening Sales and Growth Rate (2017-2027)
8.5.8.2. India Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.9. Southeast Asia
8.5.9.1. Southeast Asia Blood Screening Sales and Growth Rate (2017-2027)
8.5.9.2. Southeast Asia Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.10. Rest of Asia-Pacific
8.5.10.1. Rest of Asia-Pacific Blood Screening Sales and Growth Rate (2017-2027)
8.5.10.2. Rest of Asia-Pacific Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America
8.6.1. South America Blood Screening Sales and Growth Rate (2017-2027)
8.6.2. South America Blood Screening Revenue and Growth Rate (2017-2027)
8.6.3. South America Blood Screening Sales by Countries (2017-2027)
8.6.4. South America Blood Screening Revenue (Million USD) by Countries (2017-2027)
8.6.5. Brazil
8.6.5.1. Brazil Blood Screening Sales and Growth Rate (2017-2027)
8.6.5.2. Brazil Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Argentina
8.6.6.1. Argentina Blood Screening Sales and Growth Rate (2017-2027)
8.6.6.2. Argentina Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.7. Columbia
8.6.7.1. Columbia Blood Screening Sales and Growth Rate (2017-2027)
8.6.7.2. Columbia Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.8. Rest of South America
8.6.8.1. Rest of South America Blood Screening Sales and Growth Rate (2017-2027)
8.6.8.2. Rest of South America Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa
8.7.1. Middle East and Africa Blood Screening Sales and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Blood Screening Revenue and Growth Rate (2017-2027)
8.7.3. Middle East and Africa Blood Screening Sales by Countries (2017-2027)
8.7.4. Middle East and Africa Blood Screening Revenue (Million USD) by Countries (2017-2027)
8.7.5. Saudi Arabia
8.7.5.1. Saudi Arabia Blood Screening Sales and Growth Rate (2017-2027)
8.7.5.2. Saudi Arabia Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. United Arab Emirates
8.7.6.1. United Arab Emirates Blood Screening Sales and Growth Rate (2017-2027)
8.7.6.2. United Arab Emirates Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. Egypt
8.7.7.1. Egypt Blood Screening Sales and Growth Rate (2017-2027)
8.7.7.2. Egypt Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Nigeria
8.7.8.1. Nigeria Blood Screening Sales and Growth Rate (2017-2027)
8.7.8.2. Nigeria Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. South Africa
8.7.9.1. South Africa Blood Screening Sales and Growth Rate (2017-2027)
8.7.9.2. South Africa Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.10. Rest of Middle East and Africa
8.7.10.1. Rest of Middle East and Africa Blood Screening Sales and Growth Rate (2017-2027)
8.7.10.2. Rest of Middle East and Africa Blood Screening Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Bio-Rad Laboratories Inc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.1.4. Sales, Revenue and Market Share
9.2. Abbott Laboratories
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.2.4. Sales, Revenue and Market Share
9.3. Becton
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.3.4. Sales, Revenue and Market Share
9.4. Dickinson and Company
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.4.4. Sales, Revenue and Market Share
9.5. Beckman Coulter Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.5.4. Sales, Revenue and Market Share
9.6. Ortho Clinical Diagnostics Inc.
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.6.4. Sales, Revenue and Market Share
9.7. Thermo Fisher Scientific Inc.
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.7.4. Sales, Revenue and Market Share
9.8. bioMérieux
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.8.4. Sales, Revenue and Market Share
9.9. Siemens Healthineers
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.9.4. Sales, Revenue and Market Share
9.10. Roche Diagnostics.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3. Strategic Developments
9.10.4. Sales, Revenue and Market Share
9.11. Grifols
9.11.1. Business Overview
9.11.2. Product Portfolio
9.11.3. Strategic Developments
9.11.4. Sales, Revenue and Market Share
10. Global Blood Screening Market Competition, by Manufacturer
10.1. Global Blood Screening Sales and Market Share by Manufacturer (2017-2017)
10.2. Global Blood Screening Revenue and Market Share by Manufacturer (2017-2017)
10.3. Global Blood Screening Price by Manufacturer (2017-2017)
10.4. Top 5 Blood Screening Manufacturer Market Share
10.5. Market Competition Trend
11. Blood Screening Market Forecast (2027-2023)
11.1. Global Blood Screening Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
11.2. Blood Screening Market Forecast by Regions (2027-2023)
11.2.1. North America Blood Screening Market Forecast (2027-2023)
11.2.1.1. United States Blood Screening Market Forecast (2027-2023)
11.2.1.2. Canada Blood Screening Market Forecast (2027-2023)
11.2.1.3. Mexico Blood Screening Market Forecast (2027-2023)
11.2.2. Europe Blood Screening Market Forecast (2027-2023)
11.2.2.1. Germany Blood Screening Market Forecast (2027-2023)
11.2.2.2. United Kingdom Blood Screening Market Forecast (2027-2023)
11.2.2.3. France Blood Screening Market Forecast (2027-2023)
11.2.2.4. Russia Blood Screening Market Forecast (2027-2023)
11.2.2.5. Italy Blood Screening Market Forecast (2027-2023)
11.2.2.6. Rest of the Europe Blood Screening Market Forecast (2027-2023)
11.2.3. Asia-Pacific Blood Screening Market Forecast (2027-2023)
11.2.3.1. China Blood Screening Market Forecast (2027-2023)
11.2.3.2. Japan Blood Screening Market Forecast (2027-2023)
11.2.3.3. Korea Blood Screening Market Forecast (2027-2023)
11.2.3.4. India Blood Screening Market Forecast (2027-2023)
11.2.3.5. Southeast Asia Blood Screening Market Forecast (2027-2023)
11.2.3.6. Rest of Asia-Pacific Blood Screening Market Forecast (2027-2023)
11.2.4. South America Blood Screening Market Forecast (2027-2023)
11.2.4.1. Brazil Blood Screening Market Forecast (2027-2023)
11.2.4.2. Argentina Blood Screening Market Forecast (2027-2023)
11.2.4.3. Columbia Blood Screening Market Forecast (2027-2023)
11.2.4.4. Rest of South America Blood Screening Market Forecast (2027-2023)
11.2.5. Middle East and Africa Blood Screening Market Forecast (2027-2023)
11.2.5.1. Saudi Arabia Blood Screening Market Forecast (2027-2023)
11.2.5.2. UAE Blood Screening Market Forecast (2027-2023)
11.2.5.3. Egypt Blood Screening Market Forecast (2027-2023)
11.2.5.4. Nigeria Blood Screening Market Forecast (2027-2023)
11.2.5.5. South Africa Blood Screening Market Forecast (2027-2023)
11.2.5.6. Rest of MEA Blood Screening Market Forecast (2027-2023)
11.3. Blood Screening Market Forecast By Test Type (2027-2023)
11.3.1. Global Blood Screening Sales Forecast By Test Type (2027-2023)
11.3.2. Global Blood Screening Sales Market Share Forecast By Test Type (2027-2023)
11.4. Blood Screening Market Forecast by Product (2027-2023)
11.4.1. Global Blood Screening Sales Forecast by Product(2027-2023)
11.4.2. Global Blood Screening Sales Market Share Forecast by Product (2027-2023)
11.5. Blood Screening Market Forecast By End User (2027-2023)
11.5.1. Global Blood Screening Sales Forecast By End User (2027-2023)
11.5.2. Global Blood Screening Sales Market Share Forecast By End User (2027-2023)
*You can glance through the list of Tables and Figures when you view the sample copy of Blood Screening Market.
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Blood Screening Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|